Systemic C-reactive protein and vitamin D are not associated with development of chronic musculoskeletal pain over a 2–7 year follow-up period

Prior studies report association between elevated C-reactive protein (CRP), low vitamin D and development of chronic musculoskeletal pain. However, these small studies did not consider relevant and potentially influential biopsychosocial factors. This longitudinal study using UK Biobank data explored associations between baseline (2006-2010; T1) systemic (blood) levels of CRP and vitamin D, biopsychosocial and lifestyle factors, and later presence of chronic musculoskeletal pain (2012-2013; T2; neck/shoulder, back, hip, knee, and 'any pain' aggregation). All participants were free of pain at T1 (N=7564). At T2, N=1531 (20.2%) reported chronic musculoskeletal pain (mean [SD] age 57.9 [7.2] years, 52.5% female) and N=6033 (79.8%) remained pain-free (mean [SD] age 57.6 [7.3] years, 49.2% female). Median (IQR) T1 CRP levels were higher in those who developed chronic musculoskeletal pain at T2 ('any pain' 1.21 mg/L [1.74]) compared to those who did not (1.03 mg/L [1.53]; z range -4.67 to -2.23, p≤0.026). Higher CRP levels at T1 were associated with chronic musculoskeletal pain at T2 for all pain types (OR range 1.10-1.22, p≤0.04) after controlling for age and sex, but not after further controlling for biopsychosocial and lifestyle factors. No significant associations were found between vitamin D levels at T1 and chronic musculoskeletal pain at T2. Results suggest that systemic CRP is not associated with development of chronic musculoskeletal pain over a 2-7-year follow-up period. Additional work is needed to further characterize possible interactions between systemic CRP, other inflammatory biomarkers, and biopsychosocial factors in development of chronic musculoskeletal pain. PERSPECTIVE: This study explored whether systemic levels of C-reactive protein (CRP) and vitamin D in pain-free individuals predicted later chronic musculoskeletal pain (CMP). After accounting for biopsychosocial and lifestyle factors, CRP was not associated with later CMP. Vitamin D was not associated with later CMP in any of the models.

Authors

Institutions

Publication Details

Journal
Journal of Pain
Published
2026-04-23
DOI
https://doi.org/10.1016/j.jpain.2026.106297
Primary Topic
Vitamin D Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Systemic C-reactive protein and vitamin D are not associated with development of chronic musculoskeletal pain over a 2–7 year follow-up period

Scott F. Farrell, Nigel R Armfield, Yanfei Xie, Peter J. Cabot et al.
Journal of Pain
Vitamin D Research Studies
article

Systemic C-reactive protein and vitamin D are not associated with development of chronic musculoskeletal pain over a 2–7 year follow-up period

Scott F. Farrell, Nigel R Armfield, Yanfei Xie, Peter J. Cabot, David M. Klyne, Martin R. Collyer, Rachel A Elphinston
article en

Abstract

Prior studies report association between elevated C-reactive protein (CRP), low vitamin D and development of chronic musculoskeletal pain. However, these small studies did not consider relevant and potentially influential biopsychosocial factors. This longitudinal study using UK Biobank data explored associations between baseline (2006-2010; T1) systemic (blood) levels of CRP and vitamin D, biopsychosocial and lifestyle factors, and later presence of chronic musculoskeletal pain (2012-2013; T2; neck/shoulder, back, hip, knee, and 'any pain' aggregation). All participants were free of pain at T1 (N=7564). At T2, N=1531 (20.2%) reported chronic musculoskeletal pain (mean [SD] age 57.9 [7.2] years, 52.5% female) and N=6033 (79.8%) remained pain-free (mean [SD] age 57.6 [7.3] years, 49.2% female). Median (IQR) T1 CRP levels were higher in those who developed chronic musculoskeletal pain at T2 ('any pain' 1.21 mg/L [1.74]) compared to those who did not (1.03 mg/L [1.53]; z range -4.67 to -2.23, p≤0.026). Higher CRP levels at T1 were associated with chronic musculoskeletal pain at T2 for all pain types (OR range 1.10-1.22, p≤0.04) after controlling for age and sex, but not after further controlling for biopsychosocial and lifestyle factors. No significant associations were found between vitamin D levels at T1 and chronic musculoskeletal pain at T2. Results suggest that systemic CRP is not associated with development of chronic musculoskeletal pain over a 2-7-year follow-up period. Additional work is needed to further characterize possible interactions between systemic CRP, other inflammatory biomarkers, and biopsychosocial factors in development of chronic musculoskeletal pain. PERSPECTIVE: This study explored whether systemic levels of C-reactive protein (CRP) and vitamin D in pain-free individuals predicted later chronic musculoskeletal pain (CMP). After accounting for biopsychosocial and lifestyle factors, CRP was not associated with later CMP. Vitamin D was not associated with later CMP in any of the models.

Journal of PainVol. 44
The University of Queensland (AU)
Motor Accident Insurance Commission, National Health and Medical Research Council
Zero hunger
Openalex Percentile: Top 18%
Vitamin D Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.